ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,255 | -50.2% | 127,277 | -10.7% | 0.00% | – |
| Q2 2023 | $1,356,809 | -71.8% | 142,599 | -67.5% | 0.00% | -100.0% |
| Q1 2023 | $4,819,085 | +87807.4% | 438,115 | +18.3% | 0.00% | 0.0% |
| Q4 2022 | $5,482 | -99.9% | 370,490 | +18.0% | 0.00% | 0.0% |
| Q3 2022 | $5,999,000 | -10.0% | 313,943 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $6,664,000 | +52.2% | 312,608 | +37.5% | 0.00% | +100.0% |
| Q1 2022 | $4,378,000 | +70.4% | 227,383 | +83.5% | 0.00% | 0.0% |
| Q4 2021 | $2,569,000 | +35.6% | 123,906 | +56.1% | 0.00% | 0.0% |
| Q3 2021 | $1,894,000 | +48.3% | 79,395 | +69.7% | 0.00% | – |
| Q2 2021 | $1,277,000 | – | 46,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $95,526,552 | 6.92% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $33,000 | 4.12% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $6,259,451 | 2.58% |
| Opaleye Management Inc. | 502,000 | $5,522,000 | 1.65% |
| 1492 Capital Management LLC | 223,516 | $2,458,676 | 1.52% |
| MIRABELLA FINANCIAL SERVICES LLP | 45,299 | $9,849,004 | 1.49% |
| Saturn V Capital Management LP | 178,217 | $1,960,387 | 1.46% |
| AlphaCentric Advisors LLC | 190,000 | $2,090,000 | 1.44% |
| Rubric Capital Management LP | 3,500,000 | $38,500,000 | 1.00% |
| MPM BioImpact LLC | 254,137 | $2,795,507 | 0.73% |